We've detected that Javascript is not enabled. It is required for an optimal survey taking experience.
Please check your browser's settings and make sure Javascript is turned on. Learn how to enable Javascript.

Skip survey header

2018 COG/ASPHO Joint Sponsorship: Recent Advances in the Understanding and Treatment of Pediatric CNS Malignancies

1. Name (as you would like it to appear on your certificate): *This question is required.

2. E-mail Address: *This question is required. This question requires a valid email address.

3. How valuable is the content of this session for you? *This question is required.

4. Objectives:

Describe results of recently completed trials in pediatric CNS tumors and an approach to the development of future clinical trials in CNS malignancies;
Recognize the WHO 2016 as it relates to pediatric CNS tumors, with an emphasis on molecular diagnostic tools utilized in the clinical arena;
Discuss recent biological advances in pediatric brain tumors and implications for future clinical management;
Describe trends and current applications of radiotherapy in the management of pediatric CNS malignancies.

*This question is required.Please rate your level of agreement with the following statement:
Presenters met stated learning objectives

5. Speaker Evaluation-Please rate your level of agreement for each speaker on the following: *This question is required.Presenter was effective

Space Cell	5-Agree Strongly	4-Agree Moderately	3-Neither Agree nor Disagree	2-Disagree Moderately	1-Disagree Strongly	N/A
Naomi Winick, MD	Naomi Winick, MD: 5-Agree Strongly	Naomi Winick, MD: 4-Agree Moderately	Naomi Winick, MD: 3-Neither Agree nor Disagree	Naomi Winick, MD: 2-Disagree Moderately	Naomi Winick, MD: 1-Disagree Strongly	Naomi Winick, MD: N/A
Sarah Leary, MD	Sarah Leary, MD: 5-Agree Strongly	Sarah Leary, MD: 4-Agree Moderately	Sarah Leary, MD: 3-Neither Agree nor Disagree	Sarah Leary, MD: 2-Disagree Moderately	Sarah Leary, MD: 1-Disagree Strongly	Sarah Leary, MD: N/A
Christine Fuller, MD	Christine Fuller, MD: 5-Agree Strongly	Christine Fuller, MD: 4-Agree Moderately	Christine Fuller, MD: 3-Neither Agree nor Disagree	Christine Fuller, MD: 2-Disagree Moderately	Christine Fuller, MD: 1-Disagree Strongly	Christine Fuller, MD: N/A
Annie Huang, MD PhD	Annie Huang, MD PhD: 5-Agree Strongly	Annie Huang, MD PhD: 4-Agree Moderately	Annie Huang, MD PhD: 3-Neither Agree nor Disagree	Annie Huang, MD PhD: 2-Disagree Moderately	Annie Huang, MD PhD: 1-Disagree Strongly	Annie Huang, MD PhD: N/A
Daphne Haas-Kogan, MD PhD	Daphne Haas-Kogan, MD PhD: 5-Agree Strongly	Daphne Haas-Kogan, MD PhD: 4-Agree Moderately	Daphne Haas-Kogan, MD PhD: 3-Neither Agree nor Disagree	Daphne Haas-Kogan, MD PhD: 2-Disagree Moderately	Daphne Haas-Kogan, MD PhD: 1-Disagree Strongly	Daphne Haas-Kogan, MD PhD: N/A
Steve Braunstein MD PhD	Steve Braunstein MD PhD: 5-Agree Strongly	Steve Braunstein MD PhD: 4-Agree Moderately	Steve Braunstein MD PhD: 3-Neither Agree nor Disagree	Steve Braunstein MD PhD: 2-Disagree Moderately	Steve Braunstein MD PhD: 1-Disagree Strongly	Steve Braunstein MD PhD: N/A
Maryam Fouladi, MD	Maryam Fouladi, MD: 5-Agree Strongly	Maryam Fouladi, MD: 4-Agree Moderately	Maryam Fouladi, MD: 3-Neither Agree nor Disagree	Maryam Fouladi, MD: 2-Disagree Moderately	Maryam Fouladi, MD: 1-Disagree Strongly	Maryam Fouladi, MD: N/A

6. Demonstrated expertise in content area *This question is required.

Space Cell	5-Agree Strongly	4-Agree Moderately	3-Neither Agree nor Disagree	2-Disagree Moderately	1-Disagree Strongly	N/A
Naomi Winick, MD	Naomi Winick, MD: 5-Agree Strongly	Naomi Winick, MD: 4-Agree Moderately	Naomi Winick, MD: 3-Neither Agree nor Disagree	Naomi Winick, MD: 2-Disagree Moderately	Naomi Winick, MD: 1-Disagree Strongly	Naomi Winick, MD: N/A
Sarah Leary, MD	Sarah Leary, MD: 5-Agree Strongly	Sarah Leary, MD: 4-Agree Moderately	Sarah Leary, MD: 3-Neither Agree nor Disagree	Sarah Leary, MD: 2-Disagree Moderately	Sarah Leary, MD: 1-Disagree Strongly	Sarah Leary, MD: N/A
Christine Fuller, MD	Christine Fuller, MD: 5-Agree Strongly	Christine Fuller, MD: 4-Agree Moderately	Christine Fuller, MD: 3-Neither Agree nor Disagree	Christine Fuller, MD: 2-Disagree Moderately	Christine Fuller, MD: 1-Disagree Strongly	Christine Fuller, MD: N/A
Annie Huang, MD PhD	Annie Huang, MD PhD: 5-Agree Strongly	Annie Huang, MD PhD: 4-Agree Moderately	Annie Huang, MD PhD: 3-Neither Agree nor Disagree	Annie Huang, MD PhD: 2-Disagree Moderately	Annie Huang, MD PhD: 1-Disagree Strongly	Annie Huang, MD PhD: N/A
Daphne Haas-Kogan, MD PhD	Daphne Haas-Kogan, MD PhD: 5-Agree Strongly	Daphne Haas-Kogan, MD PhD: 4-Agree Moderately	Daphne Haas-Kogan, MD PhD: 3-Neither Agree nor Disagree	Daphne Haas-Kogan, MD PhD: 2-Disagree Moderately	Daphne Haas-Kogan, MD PhD: 1-Disagree Strongly	Daphne Haas-Kogan, MD PhD: N/A
Steve Braunstein MD PhD	Steve Braunstein MD PhD: 5-Agree Strongly	Steve Braunstein MD PhD: 4-Agree Moderately	Steve Braunstein MD PhD: 3-Neither Agree nor Disagree	Steve Braunstein MD PhD: 2-Disagree Moderately	Steve Braunstein MD PhD: 1-Disagree Strongly	Steve Braunstein MD PhD: N/A
Maryam Fouladi, MD	Maryam Fouladi, MD: 5-Agree Strongly	Maryam Fouladi, MD: 4-Agree Moderately	Maryam Fouladi, MD: 3-Neither Agree nor Disagree	Maryam Fouladi, MD: 2-Disagree Moderately	Maryam Fouladi, MD: 1-Disagree Strongly	Maryam Fouladi, MD: N/A

7. Presentation was scientifically rigorous, balanced, and free of commercial bias *This question is required.

Space Cell	5-Agree Strongly	4-Agree Moderately	3-Neither Agree nor Disagree	2-Disagree Moderately	1-Disagree Strongly	N/A
Naomi Winick, MD	Naomi Winick, MD: 5-Agree Strongly	Naomi Winick, MD: 4-Agree Moderately	Naomi Winick, MD: 3-Neither Agree nor Disagree	Naomi Winick, MD: 2-Disagree Moderately	Naomi Winick, MD: 1-Disagree Strongly	Naomi Winick, MD: N/A
Sarah Leary, MD	Sarah Leary, MD: 5-Agree Strongly	Sarah Leary, MD: 4-Agree Moderately	Sarah Leary, MD: 3-Neither Agree nor Disagree	Sarah Leary, MD: 2-Disagree Moderately	Sarah Leary, MD: 1-Disagree Strongly	Sarah Leary, MD: N/A
Christine Fuller, MD	Christine Fuller, MD: 5-Agree Strongly	Christine Fuller, MD: 4-Agree Moderately	Christine Fuller, MD: 3-Neither Agree nor Disagree	Christine Fuller, MD: 2-Disagree Moderately	Christine Fuller, MD: 1-Disagree Strongly	Christine Fuller, MD: N/A
Annie Huang, MD PhD	Annie Huang, MD PhD: 5-Agree Strongly	Annie Huang, MD PhD: 4-Agree Moderately	Annie Huang, MD PhD: 3-Neither Agree nor Disagree	Annie Huang, MD PhD: 2-Disagree Moderately	Annie Huang, MD PhD: 1-Disagree Strongly	Annie Huang, MD PhD: N/A
Daphne Haas-Kogan, MD PhD	Daphne Haas-Kogan, MD PhD: 5-Agree Strongly	Daphne Haas-Kogan, MD PhD: 4-Agree Moderately	Daphne Haas-Kogan, MD PhD: 3-Neither Agree nor Disagree	Daphne Haas-Kogan, MD PhD: 2-Disagree Moderately	Daphne Haas-Kogan, MD PhD: 1-Disagree Strongly	Daphne Haas-Kogan, MD PhD: N/A
Steve Braunstein, MD PhD	Steve Braunstein, MD PhD: 5-Agree Strongly	Steve Braunstein, MD PhD: 4-Agree Moderately	Steve Braunstein, MD PhD: 3-Neither Agree nor Disagree	Steve Braunstein, MD PhD: 2-Disagree Moderately	Steve Braunstein, MD PhD: 1-Disagree Strongly	Steve Braunstein, MD PhD: N/A
Maryam Fouladi, MD	Maryam Fouladi, MD: 5-Agree Strongly	Maryam Fouladi, MD: 4-Agree Moderately	Maryam Fouladi, MD: 3-Neither Agree nor Disagree	Maryam Fouladi, MD: 2-Disagree Moderately	Maryam Fouladi, MD: 1-Disagree Strongly	Maryam Fouladi, MD: N/A

8. Please identify how you will change your practice as a result of attending this activity (select all that apply). *This question is required.

This activity validated my current practice; no changes will be made
Create/revise protocols, policies, and/or procedures
Change the management and/or treatment of my patients
Other (please specify) Please enter an 'other' value for this selection.

9. Specifically, what change(s) do you intend to make? *This question is required.

10. Other comments regarding the session: